Persistent health complications in COVID-19 hospitalized patients at tertiary care hospital in Western India

Table 1 Comparative analysis of persistent coronavirus disease 2019

		Alive	Expired	Total	P value
Count among the discharged moderate to severe COVID-19 patients	n	1052	87	1139
	Percentage	92.36%	7.64%	100%
Gender distribution	Female	357	36	393	0.16
		90.84%	9.16%	100%
	Male	695	51	746
		93.16%	6.84%	100%

COVID-19: Coronavirus disease 2019.

Table 2 Comparative analysis of persistent coronavirus disease 2019 among the alive patients

Among the alive patients (n = 1052)		Count	Percentage (%)
Complications developed after COVID-19	Yes	150	14.25
Complications requiring treatment	Yes	51	4.85
Post COVID-19 complications management	Post-COVID	33	3.14
Post-COVID management of pre-existing conditions	Pre-COVID	18	1.71
Reason for management of pre-existing conditions post-COVID	Endocrinology	8	0.76
	Heart	6	0.57
	Lung	2	0.19
	Muscle/bone	2	0.19
Reason for treatment of post COVID-19 complications	Endocrinology	18	1.71
	Heart	14	1.33
	Lung	10	0.95
	Muscle/bone	6	0.57
	Neurological psychology	2	0.19
	Vision/hearing	1	0.09
Complications developed after COVID-19	Yes	150	14.25
Lung disease	Yes	27	2.57
Body pain	Yes	20	1.90
Coronary artery disease/angioplasty	Yes	17	1.61
Diabetes mellitus	Yes	17	1.61
Hypertension	Yes	16	1.52
Fatigue	Yes	13	1.24
Arthritis	Yes	7	0.66
Stroke	Yes	7	0.66
Kidney disease	Yes	5	0.47
Asthma	Yes	4	0.38
Thyroid disease	Yes	4	0.38
Headache/dizziness	Yes	4	0.38
Cancer/chemotherapy	Yes	3	0.28
Haemorrhoids	Yes	2	0.19
Alopecia	Yes	2	0.19
Allergy rhinitis	Yes	2	0.19
Gastroenteritis	Yes	2	0.19
Polycystic ovarian disease	Yes	1	0.09
Tuberculosis	Yes	1	0.09
Allergy	Yes	1	0.09
Anxiety	Yes	1	0.09
Clotting	Yes	1	0.09
Liver disease	Yes	1	0.09
Fungemia	Yes	1	0.09
backbone surgery	Yes	1	0.09
Vaccination status	Yes	1041	98.95
Booster dose of vaccine taken	Yes	816	77.57
Type/name of vaccine	COVAXIN	243	22.24
	COVISHIELD	771	73.29
	SPUTNIK	7	0.66
Total doses of vaccination	0	11	1.04
	1	103	9.79
	2	122	11.59
	3	816	77.57
Follow up hospital visit	Yes	179	17.01

COVID-19: Coronavirus disease 2019.

Table 3 Analysis of vaccines doses and booster doses with post coronavirus disease 2019 diseases, n (%)

		Total number of vaccines				Total	P value
		0	1	2	3 and above
		11 (1.04)	103 (9.79)	122 (11.59)	816 (77.57)	1052 (100)
Ongoing treatment for post COVID-19 complication	Yes	2 (18.2)	3 (2.9)	8 (6.6)	38 (4.7)	51 (4.8)	0.116
Ongoing management for type of complications	Complications developed after COVID-19	1 (9.1)	1 (1.0)	7 (5.7)	24 (2.9)	33 (3.1)	0.21
	Post-COVID management of pre-existing conditions	1 (9.1)	2 (1.9)	1 (0.8)	14 (1.7)	18 (1.7)
Disease developed after COVID-19	Yes	2 (18.2)	12 (11.7)	19 (15.6)	117 (14.3)	150 (14.3)	0.81

COVID-19: Coronavirus disease 2019.